Related Experiment Video
Updated: Jul 3, 2026
07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons
1Department of Neuroscience, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois 60064-3095, USA.
Journal of Neurochemistry
|August 5, 2008
Summary
Dopamine D1 receptors regulate NMDA receptor surface expression in the prefrontal cortex via tyrosine phosphorylation, not PKA. This finding is crucial for understanding addiction and psychiatric disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatric Research
Background:
- Dopamine (DA) and glutamate systems interact in the prefrontal cortex (PFC).
- These interactions are implicated in addiction and psychiatric disorders.
Purpose of the Study:
- To investigate how dopamine receptor activation affects NMDA receptor surface expression in rat PFC neurons.
- To elucidate the signaling pathways involved in this regulation.
Main Methods:
- Primary cultures of postnatal rat PFC neurons.
- Immunocytochemistry to detect surface NR1, NR2A, and NR2B subunits.
- D1 receptor agonist (SKF 81297) and tyrosine kinase inhibitor (genistein) treatments.
- Protein cross-linking and phospho-specific antibodies.
Main Results:
- D1 receptor activation increased surface expression of NR1 and NR2B subunits.
- This effect was blocked by genistein, indicating a role for tyrosine kinase.
- Tyrosine phosphorylation of NR2B at Y1472 increased upon D1 receptor activation.
- NR2A subunit surface expression was unaffected.
Conclusions:
- Dopamine D1 receptors regulate NMDA receptor trafficking in PFC neurons.
- Tyrosine phosphorylation is a key mechanism mediating this regulation, particularly for NR2B-containing receptors.
- This pathway is distinct from protein kinase A (PKA) signaling.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...